Trials / Unknown
UnknownNCT01618110
Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders
Transcranial Magnetic Stimulation of the Pre-Frontal Cortex in the Treatment of Attention Deficit/Hyperactivity Disorders: A Randomized, Controlled, Double Blind Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Shalvata Mental Health Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
* ADHD is one of the most common psychiatric disorders. * While most of the attention is directed towards youth, 60% continue to suffer symptoms into adult life. * Current treatment is effective, but 30% suffer side effects that lowers QOL, and 20% are non-responders. * Known mechanism of pathophysiology includes hypoactive dopaminergic system, especially at right PFC. * It is this study hypothesis that by stimulating the right PFC by TMS, it will be possible to alleviate ADHD symptoms. * A 10 sessions of treatment will by applied on a randomly allocated group of patients, diagnosed with ADHD, in a 2:1 ratio: The first group will receive an actual TMS treatment, and the second group will receive a sham treatment. * Improvement of objective and subjective ADHD scale will be examined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Magnetic Stimulation (Magstim, Rapid) | Superficial rTMS, directed at right PFC, power of 100% of MT, 10Hz for 4 seconds, intervals of 30 seconds, 42 trains. |
| OTHER | Placebo Treatment | Sham coil (minimal magnetic field, same noise and feeling) |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2012-06-13
- Last updated
- 2012-06-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01618110. Inclusion in this directory is not an endorsement.